| Name | Title | Contact Details |
|---|
Universal Sompo is a Joint venture of Indian Bank, Indian Overseas Bank, Karnataka Bank, Dabur Investments, and Sompo Japan Insurance Inc. The companys paid-up capital is Rs 368 Cr; Shareholders Net worth is over Rs. 1269 Cr ; Gross Written Premium Rs. 4169 Cr ; Assets Under Management (AUM) Rs. 4386 Cr; Solvency at 1.73 times. The company is headquartered in Mumbai and has 151 offices countrywide with representation through its digitally enabled employees. It has a strong distribution network of Agents, Point of salespersons, Bank Branches, Automobile Dealers, Brokers, Common Service Centres, and Digital Platforms. The company offers 234 IRDAI-approved products and 1494 Add-on covers, ranging from Motor, Accident & Health, Home for Individuals, Shopkeepers Package, Crop and other non-life packages for SMEs, Fire, Marine, Engineering, Employees Benefit, Project Insurance, Liability, and other special products for Corporates. Microinsurance covers the Rural segment. The company maintains its Claims settlement ratio at 98.87% and has robust technology architecture to serve its customers nationwide.
GEICO is a Maryland-based financial institution that provides personal and commercial insurance products for individuals and businesses.
The WSAVA represents more than 200,000 veterinarians worldwide through its 110 member associations and works to enhance standards of clinical care for companion animals. Its core activities include the development of WSAVA Global Guidelines in key areas of companion animal veterinary practice and lobbying on important issues affecting companion animal care worldwide.
Spray Foam Insulation Systems
bPrescient is a full-service scientific and technology consultancy dedicated to meeting the information management, data science, and analytics needs of the biotech, pharmaceutical, diagnostics, and healthcare industries. With bPrescients industry-leading ecosystem of experts, we offer a unique combination of both depth and breadth of knowledge to provide comprehensive support across: • The entire drug discovery process (from early-stage research to commercialization) • The diagnostics R&D lifecycle • The innovation challenges of the provider / payer domains At bPrescient, we pride ourselves on solving highly complex and difficult challenges. Our clients trust us to provide effective solutions to the problems they face today while anticipating, and helping them avoid, future challenges that catch many organizations unaware. There are three classes of problems we solve for clients: • Strategic & Advisory • Analytical & Scientific • Systems Integration, Design & Build Central to our model is the building of long-term relationships with our clients, which is why we go above and beyond to deliver exceptional results and value to those who need our assistance. Whether you are facing specific challenges today or are thinking about longer-term strategic goals, bPrescient is here to provide the support you need to succeed in the highly competitive biotech, pharmaceutical, diagnostics, and healthcare industries.